MergerJun 22, 2026, 07:02 AM
LakeShore Biopharma Shareholders Approve Merger Agreement
AI Summary
LakeShore Biopharma Co., Ltd. announced that its shareholders approved the merger agreement with Oceanpine Skyline Inc. and Oceanpine Merger Sub Inc. at an extraordinary general meeting. The agreement, which will result in LakeShore Biopharma becoming a wholly owned subsidiary of Oceanpine Skyline Inc., was approved by approximately 86.2% of the total votes cast. Upon completion, the company will become privately held, and its shares and warrants will no longer be listed on public markets.
Key Highlights
- Shareholders approved the previously announced merger agreement.
- The merger is with Oceanpine Skyline Inc. and Oceanpine Merger Sub Inc.
- The agreement was approved by approximately 86.2% of total votes cast.
- The company will become a wholly owned subsidiary of Oceanpine Skyline Inc.
- LakeShore Biopharma will become a privately held company.
- Shares and warrants will be delisted from public markets.
Price Impact
More from LSBCF